aica ribonucleotide has been researched along with Hepatitis, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ai, Q; Che, Q; Ge, P; Gong, X; Lin, L; Wan, J; Wen, A; Zhang, L; Zhou, D | 1 |
1 other study(ies) available for aica ribonucleotide and Hepatitis, Animal
Article | Year |
---|---|
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates LPS/D-Gal-induced acute hepatitis in mice.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Caspases; Disease Models, Animal; Galactose; Hepatitis, Animal; Humans; Hypoglycemic Agents; Lipopolysaccharides; Liver; Male; Mice; Molecular Targeted Therapy; Nitric Oxide; Ribonucleotides; Transaminases; Tumor Necrosis Factor-alpha | 2015 |